• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018
  • Share to Weibo added to Biovista Vizit October 25, 2017

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

IPILIMUMAB

Immune checkpoint blockade in cancer immunotherapy

August 28, 2018Cancer, Cancer Immunotherapy, Vizit Graphs
Immune checkpoint blockade in cancer immunotherapy

Explore immune checkpoint blockade (PD-1, CTLA-4) in cancer immunotherapy with Biovista Vizit. Explore the live graph.

Vizit Graphs Tag Cloud

IL23A DOXORUBICIN NEURODEGENERATIVE DISORDERS CLOSTRIDIUM DIFFICILE TNF IMMUNE RESPONSE ESCHERICHIA COLI APOPTOTIC PROCESS STAPHYLOCOCCUS AUREUS PARKINSON DISEASE DIABETES MELLITUS STREPTOCOCCUS PNEUMONIAE PORPHYROMONAS GINGIVALIS LISTERIA MONOCYTOGENES INSULIN CANCER CELL DEATH HELICOBACTER PYLORI CASP3 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE CELL DIVISION BREAST CANCER PSEUDOMONAS AERUGINOSA ANGIOGENESIS FOXP3 ALZHEIMER'S DISEASE SOD1 METFORMIN ERBB-2 IFNG CTLA4 AUTOPHAGY REMICADE IL17A TP53 AGING IL6 CELL PROLIFERATION CELL DIFFERENTIATION CD4 TH17 CELLS INFLAMMATION RECEPTOR RHEUMATOID ARTHRITIS CANDIDA ALBICANS

© 2019 Biovista Vizit All Rights Reserved.